FindTrial
Sign In

Role of homoeopathic medicine Bovista Lycoperdon in treatment of contact dermatitis

Clinical verification of symptoms of bovista lycoperdon in cases of contact dermatitis as mentioned in dictionary of practical materia medica by JH Clarke - a prospective interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065446
Enrollment
48
Registered
2024-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L20-L30- Dermatitis and eczema

Interventions

Intervention1: Bovista Lycoperdon: 15 months study 6months enrollment 6 months follow up 3 months data analysis Oral route of administration pill form centisimal scale 1st dose after taking case Subse

Sponsors

Bakson homoeopathic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical diagnosis of Contact dermatitis Contact dermatitis symptoms similar to Bovista Lycoperdon Consent taken

Exclusion criteria

Exclusion criteria: Pregnant and lactating females Lichenification stage will not be taken

Design outcomes

Primary

MeasureTime frame
It is expected to have a positive change on 5D Pruritis ScaleTimepoint: 6 months enrollment 6 months follow up 3 months data analysis 5D Pruritis scale to be filled at baseline in 15 days 1 month and 45 days—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Preeti Laroia

Bakson homoeopathic medical college

surabhigupta417@gmail.com8839037300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026